Glucocorticoid-induced osteoporosis update

G Adami, KG Saag - Current Opinion in Rheumatology, 2019 - journals.lww.com
Glucocorticoid-induced osteoporosis update : Current Opinion in Rheumatology
Glucocorticoid-induced osteoporosis update : Current Opinion in Rheumatology Log in or …

Methods to assess COPD medications adherence in healthcare databases: a systematic review

D Vauterin, F Van Vaerenbergh… - European …, 2023 - Eur Respiratory Soc
Background: The Global Initiative for Chronic Obstructive Lung Disease 2023 report
recommends medication adherence assessment in COPD as an action item. Healthcare …

Osteoporosis in patients with respiratory diseases

Y Ma, S Qiu, R Zhou - Frontiers in physiology, 2022 - frontiersin.org
Climate change, environmental pollution, and virus epidemics have sharply increased the
number of patients suffering from respiratory diseases in recent years. Prolonged periods of …

Drugs causing bone loss

P Vestergaard - Bone Regulators and Osteoporosis Therapy, 2020 - Springer
Drugs may cause bone loss by lowering sex steroid levels (eg, aromatase inhibitors in
breast cancer, GnRH agonists in prostate cancer, or depot medroxyprogestone acetate …

The effects of osteoporotic and non-osteoporotic medications on fracture risk and bone mineral density

AC van der Burgh, CE de Keyser, MC Zillikens… - Drugs, 2021 - Springer
Osteoporosis is a highly prevalent bone disease affecting more than 37.5 million individuals
in the European Union (EU) and the United States of America (USA). It is characterized by …

Sex differences in COPD management

MG Matera, J Ora, L Calzetta, P Rogliani… - Expert Review of …, 2021 - Taylor & Francis
Introduction: A growing body of evidence indicates that prevalence of chronic obstructive
pulmonary disease (COPD) has been increasing more rapidly among women compared to …

Galectin-1 inhibits PDGF-BB-induced proliferation and migration of airway smooth muscle cells through the inactivation of PI3K/Akt signaling pathway

X Pang, J Qiao - Bioscience reports, 2020 - portlandpress.com
Childhood asthma is one of the most common chronic childhood diseases. Platelet-derived
growth factor BB (PDGF-BB) induced airway smooth muscle cell (ASMC) proliferation and …

Risk of adverse reactions associated with inhaled corticosteroids for chronic obstructive pulmonary disease: A meta-analysis

C Lu, X Mao - Medicine, 2024 - journals.lww.com
Background: In the majority of current therapeutic regimens for chronic obstructive
pulmonary disease (COPD), bronchodilators are coupled with inhaled corticosteroids (ICS) …

Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database

G Adami, D Gatti, M Rossini, A Giollo, M Gatti… - Bone, 2024 - Elsevier
Objective Glucocorticoid-induced osteoporosis (GIOP) is a common cause of secondary
osteoporosis. However, glucocorticoid requiring diseases pose a risk themselves for …

Astragaloside IV promotes the pyroptosis of airway smooth muscle cells in childhood asthma by suppressing HMGB1/RAGE axis to inactivate NF-κb pathway

H Zhang, J Zhang, H Pan, K Yang, C Hu - Autoimmunity, 2024 - Taylor & Francis
Childhood asthma, a common chronic childhood disease, leads to high mortality and
morbidity in the world. Airway smooth muscle cells (ASMCs) is a group of multifunctional …